Non-pancreatic hyperlipasemia: A puzzling clinical entity

Table 3 Mortality as a function of different laboratory parameter in the group with non-pancreatic hyperlipasemia

	Survivors (n = 311)	Non-survivors (n = 90)	P value	AUROC	95%CI
Lipase (U/L)	278 (236-477)	288 (240-561)	0.311	0.535	0.464-0.606
Amylase (U/L)	175 (108-240)	221 (137-354)	0.001	0.618	0.543-0.693
Sodium (mmol/L)	139 (136-142)	139 (133-144)	0.78	0.510	0.430-0.589
Albumin (g/L)	36 (30-42)	29 (25-35)	< 0.001	0.725	0.665-0.784
BUN (mmol/L)	7 (4.6-15.7)	19.6 (9.2-35.4)	< 0.001	0.724	0.666-0.783
Creatinine (µmol/L)	83 (62-170)	166 (78-334)	< 0.001	0.638	0.570-0.705
GFR (mL/p/1.73 m2)	74 (32-91)	29 (13-79)	< 0.001	0.653	0.588-0.719
WBC (G/L)	9.63 (7.23-13.37)	13.19 (9.34-20.98)	< 0.001	0.679	0.615-0.743
Neutrophil granulocyte (G/L)	6.80 (4.80-10.83)	11.11 (7.89-17.76)	< 0.001	0.715	0.655-0.775
Lymphocyte (G/L)	1.39 (0.89-1.97)	0.98 (0.62-1.56)	< 0.001	0.634	0.564-0.703
NLR	5.24 (2.84-9.66)	12.64 (6.64-19.50)	< 0.001	0.747	0.691-0.803
CRP (mg/L)	27.35 (9.23-81.36)	84.74 (34.13-135.34)	< 0.001	0.696	0.637-0.756
PCT (µg/L)	0.6 (0.21-2.04)	2.16 (0.41-4.23)	0.002	0.620	0.546-0.694

For procalcitonin, the number of patients was 197 in survivor group and 77 in non- survivor group. BUN: Blood urea nitrogen; GFR: Glomerular filtration rate; WBC: White blood cell; NLR: Neutrophil-to-lymphocyte ratio; CRP: C-reactive protein; PCT: Procalcitonin. AUROC: Area under the receiver operating characteristic; CI: Confidence interval.